Live feed
Filing
SC 13D
SC 13D0000947871-20-000594·Compass Therapeutics, Inc.
Schedule 13D ownership disclosure
Olivia Ventures, Inc.
Security class unavailable
Event date: 2020-06-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 24.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-20-000594
- Form type
- SC 13D
- Filer
- Compass Therapeutics, Inc.
- CIK
- CIK 1738021
- Filed
- Jun 29, 2020
- Reporting period
- Jun 17, 2020
- Description
- Schedule 13D beneficial ownership